GENEVA, Oct. 5 -- AUSON PHARMACEUTICALS INC. filed a patent application (US2026/020995) for “NOVEL RIVAROXABAN FORMULATION”. With publication no. WO/2026/207262, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/535
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....